{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:42:36Z","timestamp":1793770956074,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073332"],"award-info":[{"award-number":["82073332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.radonc.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T02:29:26Z","timestamp":1641781766000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"168","author":[{"given":"Dongjun","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.01.003_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2022.01.003_b0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Longo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.01.003_b0015","doi-asserted-by":"crossref","first-page":"105112","DOI":"10.1016\/j.oraloncology.2020.105112","article-title":"Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial","volume":"113","author":"Vreugdenhil","year":"2021","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2022.01.003_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.759724","article-title":"Patient-reported outcomes-guided adaptive radiation therapy for head and neck cancer","volume":"11","author":"Weppler","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02876-5","article-title":"Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma","volume":"19","author":"Sumner","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.radonc.2022.01.003_b0035","first-page":"2537","article-title":"Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer","volume":"29","author":"Hamilton","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2022.01.003_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","article-title":"Lymphopenia during radiotherapy in patients with oropharyngeal cancer","volume":"145","author":"Ng","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2015.02.023","article-title":"Survival fraction at 2 Gy and gammaH2AX expression kinetics in peripheral blood lymphocytes from cancer patients: relationship with acute radiation-induced toxicities","volume":"92","author":"Pouliliou","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","article-title":"Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival","volume":"158","author":"Terrones-Campos","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2018.09.001","article-title":"Precision medicine in head and neck cancer","volume":"40","author":"Kaidar-Person","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.radonc.2022.01.003_b0060","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S1470-2045(19)30306-7","article-title":"Radioimmunotherapy for the treatment of head and neck cancer","volume":"20","author":"Karam","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0065","doi-asserted-by":"crossref","first-page":"103226","DOI":"10.1016\/j.critrevonc.2021.103226","article-title":"Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy","volume":"159","author":"Koukourakis","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2022.01.003_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12094-018-1908-2","article-title":"The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study","volume":"21","author":"Karantanos","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0075","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0080","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jamaoto.2019.0034","article-title":"Association of posttreatment lymphopenia and elevated neutrophil-to-lymphocyte ratio with poor clinical outcomes in patients with human papillomavirus-negative oropharyngeal cancers","volume":"145","author":"Lin","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2022.01.003_b0095","first-page":"28","article-title":"Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer","volume":"7","author":"Jensen","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4143\/crt.2016.595","article-title":"The prognostic value of treatment-related lymphopenia in nasopharyngeal carcinoma patients","volume":"50","author":"Liu","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2022.01.003_b0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2022.01.003_b0110","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1109","article-title":"Lymphopenia during chemoradiation\u2014foe or friend","volume":"14","author":"Patil","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.radonc.2022.01.003_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01494-7","article-title":"Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count","volume":"15","author":"Xie","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0120","doi-asserted-by":"crossref","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al: PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021, 372:n160.","DOI":"10.1136\/bmj.n160"},{"key":"10.1016\/j.radonc.2022.01.003_b0125","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp]"},{"key":"10.1016\/j.radonc.2022.01.003_b0130","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/sim.5453","article-title":"Quantifying the impact of between-study heterogeneity in multivariate meta-analyses","volume":"31","author":"Jackson","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2022.01.003_b0135","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1016\/j.ijrobp.2019.06.1530","article-title":"Low peripheral blood leukocyte counts during radiation therapy for head and neck cancer predict distant relapse and dysphagia","volume":"105","author":"Gui","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0140","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0145","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0165","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.ijrobp.2021.07.1100","article-title":"Spatial dose sparing for organs-at-risk (OARs) to decrease severe lymphopenia risks in head and neck cancer","volume":"111","author":"Kut","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0170","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/j.ijrobp.2021.07.1200","article-title":"Van Herk M.: Anatomical Association of Dose Distribution With Radiotherapy-Related Lymphopenia in Oropharynx Cancer","volume":"111","author":"Abravan","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.08.008","article-title":"Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers","volume":"86","author":"Lin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0180","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.radonc.2022.01.003_b0190","doi-asserted-by":"crossref","unstructured":"Moriya T, Kitagawa K, Hayakawa Y, Hemmi H, Kaisho T, Ueha S, et al: Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity. iScience 2021, 24:102424.","DOI":"10.1016\/j.isci.2021.102424"},{"key":"10.1016\/j.radonc.2022.01.003_b0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2022.01.003_b0200","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2022.01.003_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.radonc.2022.01.003_b0210","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1\/2 Trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.01.003_b0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40425-018-0395-x","article-title":"Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas","volume":"6","author":"Ho","year":"2018","journal-title":"J Immunother Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402200007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402200007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:19:35Z","timestamp":1759123175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402200007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"alternative-id":["S016781402200007X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.01.003","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}